3 not yet recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow Lorlatinib 100 mg: new trials by email Literature Review of Lorlatinib 100 mg trials Research Report on Lorlatinib 100 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lorlatinib in ROS1+ NSCLC With Brain Metastasis Lorlatinib 100 mg - Lung Cancer (NSCLC) | Phase 2 | Not yet recruiting | Hunan Cancer Hospital | 21 | 2025-08-15 | 2025-07-24 |
| Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer Lorlatinib 100 mg - Neoadjuvant Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Peking University People's Hospital | 25 | 2024-11-15 | 2024-11-12 |
| Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC Lorlatinib 100 mg - Lung Cancer, Non-Small Cell | Not yet recruiting | Peking University Cancer Hospital & Institute | 100 | 2024-11-10 | 2024-11-15 | |
| ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer Alectinib, Brigatinib, Lorlatinib 100 mg - NSCLC Stage IV, Sex Disorder | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 80 | 2024-08-05 | 2024-08-09 | |
| Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants Lorlatinib 50 mg, Lorlatinib 75 mg, Lorlatinib 100 mg - Adult, Drug Interactions | Phase 1 | Completed | Pfizer | 16 | 2019-08-22 | 2020-01-18 |
Carcinoma, Non-Small-Cell Lung (3) · Erectile Dysfunction (1) · Eunuchism (1) · Lung Neoplasms (1) · Sexual Dysfunction, Physiological (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Hunan Cancer Hospital (1) · Peking University Cancer Hospital & Institute (1) · Peking University People's Hospital (1) · Pfizer (1)
Belgium (1) · Italy (1)
Fan F Yang, M.D. (1)
2019 (1)